Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. Common Stockverified

GUTS

Price:

$1.98

Market Cap:

$142.94M

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to F...[Read more]

Industry

Biotechnology

IPO Date

2024-02-02

Stock Exchange

NASDAQ

Ticker

GUTS

The ROE as of December 2025 (TTM) for Fractyl Health, Inc. Common Stock (GUTS) is -3645.22%

According to Fractyl Health, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -3645.22%. This represents a change of -1392.71% compared to the average of 281.98% of the last 4 quarters.

Fractyl Health, Inc. Common Stock (GUTS) Historical ROE (quarterly & annually)

How has GUTS ROE performed in the past?

The mean historical ROE of Fractyl Health, Inc. Common Stock over the last ten years is -23.69%. The current -3645.22% ROE has changed 15.29% with respect to the historical average. Over the past ten years (40 quarters), GUTS's ROE was at its highest in in the September 2025 quarter at 1.43%. The ROE was at its lowest in in the March 2025 quarter at -372.31%.

Quarterly (TTM)
Annual

Average

-23.69%

Median

18.46%

Minimum

-241.68%

Maximum

23.72%

Fractyl Health, Inc. Common Stock (GUTS) ROE by Quarter and Year

Discovering the peaks and valleys of Fractyl Health, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 28.82%

Maximum Annual ROE = 23.72%

Minimum Annual Increase = -1119.05%

Minimum Annual ROE = -241.68%

Quarterly (TTM)
Annual
YearROEChange
2024-241.68%-1119.05%
202323.72%28.82%
202218.41%-0.51%
202118.50%4.86%
202017.65%-16.94%

Fractyl Health, Inc. Common Stock (GUTS) Average ROE

How has GUTS ROE performed in the past?

The current ROE of Fractyl Health, Inc. Common Stock (GUTS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-66.52%

5-year avg

-32.68%

10-year avg

-23.69%

Fractyl Health, Inc. Common Stock (GUTS) ROE vs. Peers

How is GUTS’s ROE compared to its peers?

Fractyl Health, Inc. Common Stock’s ROE is greater than Adverum Biotechnologies, Inc. (-3844.85%), greater than ALX Oncology Holdings Inc. (-115.67%), greater than Precision BioSciences, Inc. (-213.79%), greater than Artiva Biotherapeutics, Inc. (-45.64%), less than Sutro Biopharma, Inc. (861.99%), greater than Quince Therapeutics, Inc. (-186.08%), greater than Metagenomi, Inc. Common Stock (-38.76%), greater than Repare Therapeutics Inc. (-57.56%), greater than aTyr Pharma, Inc. (-100.11%), greater than Biomea Fusion, Inc. (-256.98%),

Build a custom stock screener for Fractyl Health, Inc. Common Stock (GUTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fractyl Health, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fractyl Health, Inc. Common Stock (GUTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fractyl Health, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Fractyl Health, Inc. Common Stock's ROE?

How is the ROE calculated for Fractyl Health, Inc. Common Stock (GUTS)?

What is the highest ROE for Fractyl Health, Inc. Common Stock (GUTS)?

What is the 3-year average ROE for Fractyl Health, Inc. Common Stock (GUTS)?

What is the 5-year average ROE for Fractyl Health, Inc. Common Stock (GUTS)?

How does the current ROE for Fractyl Health, Inc. Common Stock (GUTS) compare to its historical average?